Literature DB >> 3017836

Identification of carriers of mutant prealbumin gene associated with familial amyloidotic polyneuropathy type I by Southern blot procedures: study of six pedigrees in the Arao district of Japan.

M Ide, S Mita, S Ikegawa, S Maeda, K Shimada, S Araki.   

Abstract

Fifty-six Japanese individuals from six pedigrees with familial amyloidotic polyneuropathy (FAP), together with 2 individuals with symptomatic FAP from an unknown pedigree were analyzed, using the Southern blot procedures for the prealbumin gene structure. A human prealbumin cDNA was used as the probe. Altogether, these individuals included 20 with symptomatic FAP, 30 who were asymptomatic, and 8 disease-free spouses. Twenty individuals with symptomatic FAP were all heterozygous for the prealbumin genes, carrying one normal and one mutant gene. We confirmed the direct linkage between the mutant prealbumin gene and the Japanese type of FAP. Moreover, 10 of the 30 asymptomatic individuals from pedigrees with FAP were also heterozygous for the prealbumin gene. The number of asymptomatic individuals with the mutant prealbumin gene showed age-related decreases, and none was over 40 years. A linkage between the mutant prealbumin gene and serum levels of the prealbumin variant was also evident.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3017836     DOI: 10.1007/bf00279086

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  13 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

3.  Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants.

Authors:  L M Kunkel; K D Smith; S H Boyer; D S Borgaonkar; S S Wachtel; O J Miller; W R Breg; H W Jones; J M Rary
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

4.  Childhood detection of familial amyloidotic polyneuropathy.

Authors:  M Nakazato; T Kurihara; K Kangawa; H Matsuo
Journal:  Lancet       Date:  1985-01-12       Impact factor: 79.321

5.  Presymptomatic diagnosis of heterozygosity for familial amyloidotic polyneuropathy by recombinant DNA techniques.

Authors:  H Sasaki; Y Sakaki; Y Takagi; K Sahashi; A Takahashi; T Isobe; T Shinoda; H Matsuo; I Goto; Y Kuroiwa
Journal:  Lancet       Date:  1985-01-12       Impact factor: 79.321

6.  Cloning and sequence analysis of cDNA for human prealbumin.

Authors:  S Mita; S Maeda; K Shimada; S Araki
Journal:  Biochem Biophys Res Commun       Date:  1984-10-30       Impact factor: 3.575

7.  Polymorphism of human plasma thyroxine binding prealbumin.

Authors:  F E Dwulet; M D Benson
Journal:  Biochem Biophys Res Commun       Date:  1983-07-29       Impact factor: 3.575

8.  Type I familial amyloidotic polyneuropathy (Japanese type).

Authors:  S Araki
Journal:  Brain Dev       Date:  1984       Impact factor: 1.961

9.  Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type).

Authors:  S Tawara; M Nakazato; K Kangawa; H Matsuo; S Araki
Journal:  Biochem Biophys Res Commun       Date:  1983-11-15       Impact factor: 3.575

10.  Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin).

Authors:  M J Saraiva; S Birken; P P Costa; D S Goodman
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

View more
  8 in total

1.  Haplotype analysis of familial amyloidotic polyneuropathy. Evidence for multiple origins of the Val----Met mutation most common to the disease.

Authors:  K Yoshioka; H Furuya; H Sasaki; M J Saraiva; P P Costa; Y Sakaki
Journal:  Hum Genet       Date:  1989-04       Impact factor: 4.132

2.  Comparison of amyloid deposition in two lines of transgenic mouse that model familial amyloidotic polyneuropathy, type I.

Authors:  Y Takaoka; F Tashiro; S Yi; S Maeda; K Shimada; K Takahashi; Y Sakaki; K Yamamura
Journal:  Transgenic Res       Date:  1997-07       Impact factor: 2.788

3.  Ocular microangiopathy in familial amyloidotic polyneuropathy, type I.

Authors:  E Ando; Y Ando; S Maruoka; Y Sakai; S Watanabe; R Yamashita; R Okamura; S Araki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

Review 4.  Diagnosis of genetic disease using recombinant DNA. Supplement.

Authors:  D N Cooper; J Schmidtke
Journal:  Hum Genet       Date:  1987-09       Impact factor: 4.132

5.  Disruption of the transthyretin gene results in mice with depressed levels of plasma retinol and thyroid hormone.

Authors:  V Episkopou; S Maeda; S Nishiguchi; K Shimada; G A Gaitanaris; M E Gottesman; E J Robertson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

6.  Effect of serum amyloid P component level on transthyretin-derived amyloid deposition in a transgenic mouse model of familial amyloidotic polyneuropathy.

Authors:  T Murakami; S Yi; S Maeda; F Tashiro; K Yamamura; K Takahashi; K Shimada; S Araki
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

7.  Transthyretin gene mutations in British and French patients with amyloid neuropathy.

Authors:  K Bhatia; M Reilly; D Adams; M B Davis; C H Hawkes; P K Thomas; G Said; A E Harding
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-06       Impact factor: 10.154

8.  Analysis of amyloid deposition in a transgenic mouse model of homozygous familial amyloidotic polyneuropathy.

Authors:  K Kohno; J A Palha; K Miyakawa; M J Saraiva; S Ito; T Mabuchi; W S Blaner; H Iijima; S Tsukahara; V Episkopou; M E Gottesman; K Shimada; K Takahashi; K Yamamura; S Maeda
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.